Stock Comparison
LLY vs NVO
Eli Lilly and Company and Novo Nordisk A/S side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.04T
$204.55B
P/E (TTM)
39.1
11.4
Forward P/E
32.1
13.5
Price/Sales
13.0
0.6
Price/Book
30.6
6.0
EV/EBITDA
26.0
8.2
Dividend Yield
0.53%
3.86%
Profitability
Net Margin
33.53%
37.20%
Operating Margin
43.92%
45.30%
Return on Equity
102.30%
59.80%
Return on Assets
20.40%
18.70%
Growth (YoY)
Revenue Growth
47.70%
2.10%
Earnings Growth
26.20%
-20.60%
Price & Risk
Beta
0.5
0.3
52-Week High
$1,235.65
$61.85
52-Week Low
$679.67
$34.84
Analyst Target
$1,297.31
$47.32
Compare LLY and NVO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.